Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Asia Pacific Allergy
|
June 3, 2024
Pembrolizumab-induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis in a Vietnamese patient with nonsmall-cell lung cancer
Yen T H Pham, Mai T Vu, Anh Q Nguyen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 6, 2021
Reprogramming of the heavy-chain CDR3 regions of a human antibody repertoire
Tianling Ou, Wenhui He, Brian D Quinlan, et al.
Molecular Therapy. Nucleic Acids
|
March 19, 2021
A more efficient CRISPR-Cas12a variant derived from <i>Lachnospiraceae bacterium</i> MA2020
Mai H Tran, Hajeung Park, Christopher L Nobles, et al.
Human Gene Therapy
|
May 13, 2025
Halting Recombinant Adeno-Associated Virus Transgene Expression Using mRNA-Lipid Nanoparticle-Delivered Meganucleases
Rubens Tavora, Lizhou Zhang, Mai H Tran, et al.
BMC Infectious Diseases
|
June 19, 2022
Investigation of target sequencing of SARS-CoV-2 and immunogenic GWAS profiling in host cells of COVID-19 in Vietnam
Tham H Hoang, Giang M Vu, Mai H Tran, et al.
Nature Biomedical Engineering
|
December 5, 2024
In vivo affinity maturation of the CD4 domains of an HIV-1-entry inhibitor
Andi Pan, Charles C Bailey, Tianling Ou, et al.
Journal of the American Society of Hypertension : JASH
|
July 28, 2018
Misclassification of blood pressure of Vietnamese adults when only a single measurement is used
Nga T T Tran, Christopher L Blizzard, Khue N Luong, et al.
Ebiomedicine
|
October 21, 2023
Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18-55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trial
Keith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
The Lancet. Infectious Diseases
|
April 22, 2021
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial
Keith J Chappell, Francesca L Mordant, Zheyi Li, et al.
Clinical & Translational Immunology
|
April 12, 2021
Preclinical development of a molecular clamp-stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2
Daniel Watterson, Danushka K Wijesundara, Naphak Modhiran, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Asia Pacific Allergy
|
June 3, 2024
Pembrolizumab-induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis in a Vietnamese patient with nonsmall-cell lung cancer
Yen T H Pham, Mai T Vu, Anh Q Nguyen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 6, 2021
Reprogramming of the heavy-chain CDR3 regions of a human antibody repertoire
Tianling Ou, Wenhui He, Brian D Quinlan, et al.
Molecular Therapy. Nucleic Acids
|
March 19, 2021
A more efficient CRISPR-Cas12a variant derived from <i>Lachnospiraceae bacterium</i> MA2020
Mai H Tran, Hajeung Park, Christopher L Nobles, et al.
Human Gene Therapy
|
May 13, 2025
Halting Recombinant Adeno-Associated Virus Transgene Expression Using mRNA-Lipid Nanoparticle-Delivered Meganucleases
Rubens Tavora, Lizhou Zhang, Mai H Tran, et al.
BMC Infectious Diseases
|
June 19, 2022
Investigation of target sequencing of SARS-CoV-2 and immunogenic GWAS profiling in host cells of COVID-19 in Vietnam
Tham H Hoang, Giang M Vu, Mai H Tran, et al.
Nature Biomedical Engineering
|
December 5, 2024
In vivo affinity maturation of the CD4 domains of an HIV-1-entry inhibitor
Andi Pan, Charles C Bailey, Tianling Ou, et al.
Journal of the American Society of Hypertension : JASH
|
July 28, 2018
Misclassification of blood pressure of Vietnamese adults when only a single measurement is used
Nga T T Tran, Christopher L Blizzard, Khue N Luong, et al.
Ebiomedicine
|
October 21, 2023
Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18-55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trial
Keith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
The Lancet. Infectious Diseases
|
April 22, 2021
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial
Keith J Chappell, Francesca L Mordant, Zheyi Li, et al.
Clinical & Translational Immunology
|
April 12, 2021
Preclinical development of a molecular clamp-stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2
Daniel Watterson, Danushka K Wijesundara, Naphak Modhiran, et al.
Page
of 2